Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederthelancet.com
Get the latest updates from The Lancet directly as they happen.
Follow now 129 followers
Last updated 6 days ago
6 days ago
Gilead's lenacapavir approval by the US Food and Drug Administration (FDA) marks...
6 days ago
The conclusion from Huseyin Naci and colleagues1 that more quality-adjusted life-years (QALYs)...
6 days ago
The House of Commons has approved the Terminally Ill Adults Bill amid...
6 days ago
Conservative justices agreed with the state and Trump administration that banning minors’...
6 days ago
We appreciate the responses to our Article,1 which suggest that the health...
10 days ago
The incidence of early-onset type 2 diabetes is increasing, with a growing...
10 days ago
Early-onset type 2 diabetes (defined as type 2 diabetes diagnosed in people...
10 days ago
Early-onset type 2 diabetes (defined as type 2 diabetes diagnosed in people...
10 days ago
Considered a disease of middle-aged and older adults until the late 20th...
11 days ago
Efsitora showed non-inferior HbA1c reductions and similar rates of combined clinically significant...
11 days ago
Type 2 diabetes is characterised by insulin resistance and progressive β-cell decline...
11 days ago
Efsitora is a well tolerated and efficacious once-weekly alternative to daily basal...